Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

What gives you the right to pass judgement on Nade

Message Board Public Reply | Private Reply | Keep | Replies (4)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154810
(Total Views: 544)
Posted On: 05/01/2022 2:39:14 PM
Avatar
Posted By: Goosebumps
Re: havasu78 #122739
What gives you the right to pass judgement on Nader for the BLA being submitted before the corrupt Amarex had 2 years to remedy the issues that were itemized by the FDA? Is it not Amarex that shares most of the blame? When it is all said and done will Nader share most of the blame for the 2 years that Amarex did virtually nothing? How long are we to wait for a specialized hired talent to submit a corrected BLA application? When the FDA gave Amarex a written description of all the faults that needed corrected. They couldn’t keep a lead person on the task of correcting the BLA for submittal.

Does anyone know or remember that we had a rolling review with fast tracked designation approved by the FDA. So when we talk about who dropped the ball. Might want to look at why wasn’t the rolling review used? Seems this is a check off of all sections of a application one by one with structure and some reinsurance of a completed correct BLA as your final ending. With the chance to correct each section after being reviewed. How much easier can the process be for Amarex. Why didn’t they use this process?

When it all comes down and Sidley settles this dispute about the liabilities that Amarex has. I am sure we will be on the best side of it all. Clearly something is fishy in all of this. A frustrated email taken out of context will not allow Amarex to shrug their liability in all of this. I believe they hold more than their share of not all the liability in this failed BLA. Only time will tell.

This is just my opinion and with my opinion and a buck fifty you can buy a cup of coffee most places. Just regular brew not a Starbucks specialty coffee of coarse.


(5)
(1)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us